Search Results - "Trapani, Angelo J"

Refine Results
  1. 1

    Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial by Bomback, Andrew S., Kavanagh, David, Vivarelli, Marina, Meier, Matthias, Wang, Yaqin, Webb, Nicholas J.A., Trapani, Angelo J., Smith, Richard J.H.

    Published in Kidney international reports (01-10-2022)
    “…Complement 3 glomerulopathy (C3G) is a rare kidney disease characterized by dysregulation of the alternative pathway (AP) of the complement system. About 50%…”
    Get full text
    Journal Article
  2. 2

    Design and Synthesis of Potent, Selective Inhibitors of Endothelin-Converting Enzyme by Wallace, Eli M, Moliterni, John A, Moskal, Michael A, Neubert, Alan D, Marcopulos, Nicholas, Stamford, Lisa B, Trapani, Angelo J, Savage, Paula, Chou, Mary, Jeng, Arco Y

    Published in Journal of medicinal chemistry (23-04-1998)
    “…Endothelin-1 is the most potent peptidic vasoconstrictor discovered to date. The final step of posttranslational processing of this peptide is the conversion…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    CGS 35601 and its Orally Active Prodrug CGS 37808 as Triple Inhibitors of Endothelin-converting Enzyme-1, Neutral Endopeptidase 24.11, and Angiotensin-converting Enzyme by Trapani, Angelo J, Beil, Michael E, Bruseo, Charles W, Savage, Paula, Firooznia, Fariborz, Jeng, Arco Y

    Published in Journal of cardiovascular pharmacology (01-11-2004)
    “…CGS 35601 is a potent triple inhibitor of endothelinconverting enzyme-1, neutral endopeptidase 24.11, and angiotensinconverting enzyme. It inhibited the…”
    Get full text
    Journal Article
  6. 6

    CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11 by Jeng, Arco Y, Savage, Paula, Beil, Michael E, Bruseo, Charles W, Hoyer, Denton, Fink, Cynthia A, Trapani, Angelo J

    Published in Clinical science (1979) (01-08-2002)
    “…Endothelins (ETs) are potent vasoconstrictors and have been implicated in the pathogenesis of various cardiovascular and renal diseases. In contrast, atrial…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1 by Firooznia, Fariborz, Gude, Candido, Chan, Kenneth, Tan, Jenny, Fink, Cynthia A., Savage, Paula, Beil, Michael E., Bruseo, Charles W., Trapani, Angelo J., Jeng, Arco Y.

    Published in Bioorganic & medicinal chemistry letters (04-11-2002)
    “…Directed screening of metalloprotease inhibitors identified CGS 30084 ( 1) as a potent inhibitor of endothelin-converting enzyme-1 (ECE-1) in vitro (IC 50=77…”
    Get full text
    Journal Article
  9. 9

    Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats by Trapani, Angelo J, Beil, Michael E, Bruseo, Charles W, Fink, Cynthia A, Hoyer, Denton, Savage, Paula, Jeng, Arco Y

    Published in Clinical science (1979) (01-08-2002)
    “…CGS 34226 is a thiol-containing, potent dual inhibitor of endothelin converting enzyme-1 (ECE-1) and neutral endopeptidase 24.11 (NEP) with IC(50) values of 11…”
    Get more information
    Journal Article
  10. 10
  11. 11

    N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) Inhibitors by De Lombaert, Stephane, Erion, Mark D, Tan, Jenny, Blanchard, Louis, El-Chehabi, Lena, Ghai, R. D, Sakane, Yumi, Berry, Carol, Trapani, Angelo J

    Published in Journal of medicinal chemistry (01-02-1994)
    “…Inhibitors of the zinc protease neutral endopeptidase (NEP, EC 3.4.24.11) offer significant therapeutic interest as antihypertensives due to their ability to…”
    Get full text
    Journal Article
  12. 12

    Design and Synthesis of a Potent and Selective Endothelin-Converting Enzyme Inhibitor, CGS 35066 by Jeng, Arco Y, De Lombaert, Stéphane, Beil, Michael E, Bruseo, Charles W, Savage, Paula, Chou, Mary, Trapani, Angelo J

    “…CGS 26303 has previously been shown to inhibit human endothelin converting enzyme-1 (ECE-1) with an IC50 of 410 nM and to be efficacious in several animal…”
    Get full text
    Journal Article
  13. 13

    Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1 by Fink, Cynthia A, Moskal, Michael, Firooznia, Fariborz, Hoyer, Denton, Symonsbergen, David, Wei, Dongchu, Qiao, Ying, Savage, Paula, Beil, Michael E, Trapani, Angelo J, Jeng, Arco Y

    Published in Bioorganic & medicinal chemistry letters (04-09-2000)
    “…Through directed screening of compounds prepared as metalloprotease inhibitors a compound, CGS 30084, that had potent endothelin converting enzyme-1 (ECE-1) in…”
    Get full text
    Journal Article
  14. 14

    Pharmacological Properties of CGS 35066, a Potent and Selective Endothelin-Converting Enzyme Inhibitor, in Conscious Rats by Trapani, Angelo J, Beil, Michael E, Bruseo, Charles W, De Lombaert, Stéphane, Jeng, Arco Y

    “…The purpose of this study was to examine the pharmacologic properties of CGS 35066, a novel aminophosphonate inhibitor of endothelin-converting enzyme-1…”
    Get full text
    Journal Article
  15. 15

    Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors by FIROOZNIA, Fariborz, GUDE, Candido, TRAPANI, Angelo J, JENG, Arco Y, CHAN, Kenneth, FINK, Cynthia A, YING QIAO, SATOH, Yoshitaka, MARCOPOULOS, Nicholas, SAVAGE, Paula, BEIL, Michael E, BRUSEO, Charles W

    Published in Bioorganic & medicinal chemistry letters (12-02-2001)
    “…Through directed screening of metalloprotease inhibitors, CGS 30084 (1) has been identified as a potent endothelin-converting enzyme-1 (ECE-1) inhibitor in…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Mercaptoacyl Dipeptides as Orally Active Dual Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase by Fink, Cynthia A, Carlson, J. Eric, McTaggart, Patricia A, Qiao, Ying, Webb, Randy, Chatelain, Ricardo, Jeng, Arco Y, Trapani, Angelo J

    Published in Journal of medicinal chemistry (02-08-1996)
    “…Dual inhibitors of the two zinc metallopeptidases, neutral endopeptidase (NEP, EC 3.4.24.11) and angiotensin-I-converting enzyme (ACE, EC 2.4.15.1), have been…”
    Get full text
    Journal Article
  18. 18

    Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11 by Chatelain, R E, Ghai, R D, Trapani, A J, Odorico, L M, Dardik, B N, De Lombaert, S, Lappe, R W, Fink, C A

    “…Dual angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitors, by decreasing angiotensin-II production and by preventing the degradation of…”
    Get more information
    Journal Article
  19. 19

    New .alpha.-Thiol Dipeptide Dual Inhibitors of Angiotensin-I-Converting Enzyme and Neutral Endopeptidase EC 3.4.24.11 by Fink, Cynthia A, Qiao, Ying, Berry, Carol J, Sakane, Yumi, Ghai, Rajendra D, Trapani, Angelo J

    Published in Journal of medicinal chemistry (01-12-1995)
    “…Dual inhibitors of the two zinc metallopeptidases, neutral endopeptidase (NEP, EC 3.4.24.11) and angiotensin-I converting enzyme, have been the focus of much…”
    Get full text
    Journal Article
  20. 20

    Benzofused Macrocyclic Lactams as Triple Inhibitors of Endothelin-Converting Enzyme, Neutral Endopeptidase 24.11, and Angiotensin-Converting Enzyme by Ksander, Gary M, Savage, Paula, Trapani, Angelo J, Balwierczak, Joseph L, Jeng, Arco Y

    “…The purpose of this study was to identify endothelin-converting enzyme (ECE) inhibitors that also possess inhibitory activity for neutral endopeptidase 24.11…”
    Get full text
    Journal Article